The triad of sleep apnea, hypertension, and chronic kidney disease: A spectrum of common pathology

CardioRenal Medicine

Volumn 7, Issue 1, 2016, Pages 74-82

  Aziz, Fahad ^a   Chaudhary, Kunal ^a,b  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; Resistant hypertension; Sleep apnea; Volume overload

Indexed keywords

ALDOSTERONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; REACTIVE OXYGEN METABOLITE;

AIRWAY PRESSURE; ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; APNEA HYPOPNEA INDEX; ARTERIAL OXYGEN SATURATION; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; HEART AFTERLOAD; HUMAN; INFLAMMATION; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; RESISTANT HYPERTENSION; RESPIRATORY BURST; REVIEW; SLEEP DISORDERED BREATHING; SYMPATHETIC TONE;

EID: 84994744839     PISSN: 16643828     EISSN: 16645502     Source Type: Journal    
DOI: 10.1159/000450796     Document Type: Review

References (74)

1. Hiestand DM, Britz P, Goldman M, Phillips B. Prevalence of symptoms and risk of sleep apnea in the US population: results from the national sleep foundation sleep in America 2005 poll. Chest 2006; 130: 780-786
2. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-Aged adults. N Engl J Med 1993; 328: 1230-1235
3. Foley DJ, Monjan A, Simonsick EM, Wallace RB, Blazer DG. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6, 800 persons over three years. Sleep 1999; 22(suppl 2): S366-S372
4. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988; 94: 9-14
5. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large communitybased study. Sleep Heart Health Study. JAMA 2000; 283: 1829-1836
6. Ozkok A, Kanbay A, Odabas AR, Covic A, Kanbay M. Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor. Clin Exp Hypertens 2014; 36: 211-216
7. Kraus MA, Hamburger RJ. Sleep apnea in renal failure. Adv Perit Dial 1997; 13: 88-92
8. Adeseun GA, Rosas SE. The impact of obstructive sleep apnea on chronic kidney disease. Curr Hypertens Rep 2010; 12: 378-383
9. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667-689
10. American Academy of Sleep Medicine: International Classification of Sleep Disorders. Diagnostic and Coding Manual American Academy of Sleep Medicine, ed 2. Westchester, American Academy of Sleep Medicine, 2005
11. Guilleminault C, Bassiri A. Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome and the upper airway resistance syndrome; in Kryger MH, Roth T, Dement WC (eds): Principles and Practices of Sleep Medicine. Philadelphia, Elsevier, 2005, pp 1043-1052
12. Kuhlmann U, Bormann FG, Becker HF. Obstructive sleep apnoea: clinical signs, diagnosis and treatment. Nephrol Dial Transplant 2009; 24: 8-14
13. Ozkok A, Kanbay A, Odabas AR, Covic A, Kanbay M. Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor. Clin Exp Hypertens 2014; 36: 211-216
14. Nicholl DDM, Ahmed SB, Loewen AHS, et al. Clinical presentation of obstructive sleep apnea in patients with chronic kidney disease. J Clin Sleep Med 2012; 8: 381-387
15. Unruh ML. Sleep apnea and dialysis therapies: things that go bump in the night? Hemodial Int 2007; 11: 369-378
16. Sakaguchi Y, Shoji T, Kawabata H, et al. High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin J Am Soc Nephrol 2011; 6: 995-1000
17. Molnar MZ, Mucsi I, Novak M, Szabo Z, Freire AX, Huch KM, Arah OA, Ma JZ, Lu JL, Sim JJ, Streja E, Kalantar-Zadeh K, Kovesdy CP. Association of incident obstructive sleep apnoea with outcomes in a large cohort of US veterans. Thorax 2015; 70: 888-895
18. Lee YC, Hung SY, Wang HK, et al. Sleep apnea and the risk of chronic kidney disease: a nationwide populationbased cohort study. Sleep 2015; 38: 213-221
19. Markou N, Kanakaki M, Myrianthefs P, et al. Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung 2006; 184: 43-49
20. Fleischmann G, Fillafer G, Matterer H, et al. Prevalence of chronic kidney disease in patients with suspected sleep apnoea. Nephrol Dial Transplant 2010; 25: 181-186
21. Tada T, Kusano KF, Ogawa A, et al. The predictors of central and obstructive sleep apnoea in haemodialysis patients. Nephrol Dial Transplant 2007; 22: 1190-1197
22. Dewan NA, Nieto FJ, Somers VK. Intermittent hypoxemia and OSA: 515 implications for comorbidities. Chest 2015; 147: 266-274
23. Bradley D, Hall MJ, Ando S, Floras JS. Hemodynamic effects of simulated obstructive apneas in humans with and without heart failure. Chest 2001; 119: 1827-1835
24. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897-1904
25. Damy T, Paulino A, Margarit L, Drouot X, Stoica M, Vermes E, Gueret P, Adnot S, Rande JL, D'Ortho MP, Hittinger L. Left ventricle remodelling is associated with sleep-disordered breathing in non-ischaemic cardiopathy with systolic dysfunction. J Sleep Res 2011: 20(pt 1): 101-109
26. Drager LF, Bortolotto LA, Figueiredo AC, Silva BC, Krieger EM, Lorenzi-Filho G. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest 2007; 131: 1379-1386
27. Usui Y, Takata Y, Inoue Y, Tomiyama H, Kurohane S, Hashimura Y, Kato K, Saruhara H, Asano K, Shiina K, Yamashina A. Severe obstructive sleep apnea impairs left ventricular diastolic function in non-obese men. Sleep Med 2013; 14: 155-159
28. Abdel-Kader K, Dohar S, Shah N, et al. Resistant hypertension and obstructive sleep apnea in the setting of kidney disease. J Hypertens 2012; 30: 960-966
29. Bucca CB, Brussino L, Battisti A, et al. Diuretics in obstructive sleep apnea with diastolic heart failure. Chest 2007; 132: 440-446
30. Beecroft JM, Hoffstein V, Pierratos A, Chan CT, McFarlane PA, Hanly PJ. Pharyngeal narrowing in end-stage renal disease: implications for obstructive sleep apnea. Eur Respir J 2007; 30: 965-971
31. Elias RM, Bradley TD, Kasai T, et al. Rostral overnight fluid shift in end-stage renal disease: relationship with obstructive sleep apnea. Nephrol Dial Transplant 2012; 27: 1569-1573
32. Elias RM, Chan CT, Paul N, Motwani SS, Kasai T, Gabriel JM, Spiller N, Bradley TD. Relationship of pharyngeal water content and jugular volume with severity of obstructive sleep apnea in renal failure. Nephrol Dial Transplant 2013; 28: 937-944
33. Campese VM, Mitra N, Sandee D. Hypertension in renal parenchymal disease: why is it so resistant to treatment? Kidney Int 2006; 69: 967-973
34. Shamsuzzaman S, Gersh B, Somers V. Obstructive sleep apnea: implications for cardiac and vascular disease. J Am Med Assoc 2003; 290: 1906-1914
35. Narkiewicz K, Montano N, Cogliati C, Van De Borne P, Dyken E, Somers V. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98: 1071-1077
36. Narkiewicz K, Pesek C, Kato M, Phillips B, Davison D, Somers V. Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension 1998; 32: 1039-1043
37. Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 2010; 90: 47-112
38. Linz D, Mahfoud F, Schotten U. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension 2012; 60: 172-178
39. Mallamaci F, Leonardis D, Tripepi R, Parlongo G, Catalano C, Tripepi G, Castronovo V, Ferini-Strambi L, Zoccali C. Sleep disordered breathing in renal transplant patients. Am J Transplant 2009; 9: 1373-1381
40. Fornadi K, Ronai KZ, Turanyi CZ, Malavade TS, Shapiro CM, Novak M, Mucsi I, Molnar MZ. Sleep apnea is not associated with worse outcomes in kidney transplant recipients. Sci Rep 2014; 4: 6987
41. Greene EL, Kren S, Hostetter TH. Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 1996; 98: 1063-1068
42. Pratt-Ubunama M, Nishizaka M, Boedefeld R, Cofield S, Harding S, Calhoun D. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007; 131: 453-459
43. Gonzaga C, Gaddam K, Ahmed MI, et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. JClin Sleep Med 2010; 6: 363-368
44. Faller V. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991; 88: 1054-1057
45. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, Somers VK. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607-2610
46. Lattimore JL, Wilcox I, Skilton M, Langenfeld M, Celermajer DS. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 2006; 61: 491-495
47. Brooks D, Horner R, Kozar L, Render-Teixeira C, Phillipson E. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997; 99: 106-109
48. Belaidi E, Joyeux-Faure M, Ribuot C, Launois S, Levy P, Godin-Ribuot D. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol 2009; 53: 1309-1317
49. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005; 112: 2660-2667
50. Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000; 102: 2607-2610
51. Dursunoglu N, Dursunoglu D. Obstructive sleep apnea syndrome, endothelial dysfunction and coronary atherosclerosis (in Turkish). Tuberk Toraks 2005; 53: 299-306
52. Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, Kimura H. Oxidative stress in obstructive sleep apnea. Chest 2005; 127: 1674-1679
53. Fassett RG, Venuthurupalli SK, Gobe GC, et al. Biomarkers in chronic kidney disease: a review. Kidney Int 2011; 80: 806-821
54. Faulx MD, Storfer-Isser A, Kirchner HL, Jenny NS, Tracy RP, Redline S. Obstructive sleep apnea is associated with increased urinary albumin excretion. Sleep 2007; 30: 923-929
55. Tsioufis C, Thomopoulos C, Dimitriadis K, Amfilochiou A, Tsiachris D, Selima M, Petras D, Kallikazaros I, Stefanadis C. Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study. Am J Kidney Dis 2008; 52: 285-293
56. Ursavas A, Karadag M, Gullulu M, Demirdogen E, Coskun F, Onart S, Gozu RO. Low-grade urinary albumin excretion in normotensive/non-diabetic obstructive sleep apnea patients. Sleep Breath 2008; 12: 217-222
57. Sklar AH, Chaudhary BA. Reversible proteinuria in obstructive sleep apnea syndrome. Arch Intern Med 1988; 148: 87-89
58. Møller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16: 274-280
59. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, Ando S, Bradley TD. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 348: 1233-1241
60. Kinebuchi S, Kazama JJ, Satoh M, et al. Short-Term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. Clin Sci (Lond) 2004; 107: 317-322
61. Logan A, Tkacova R, Perlikowski S. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J 2003; 21: 241-247
62. Kinebuchi S, Kazama JJ, Satoh M, Sakai K, Nakayama H, Yoshizawa H, Narita I, Suzuki E, Gejyo F. Short-Term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. Clin Sci (Lond) 2004; 107: 317-322
63. Kita H, Ohi M, Chin K, Noguchi T, Otsuka N, Tsuboi T, Itoh H, Nakao K, Kuno K. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure. J Sleep Res 1998; 7: 199-207
64. Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; 344: 102-107
65. Tang SC, Lam B, Ku PP, leung W, Chu C, Ho Y, Ip M, lai K. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-Assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2006; 17: 2607-2616
66. Tang SC, Lam B, Lai AS, Pang CB, Tsa WK, Khong PL, Ip MS, lai KN. Improvement in sleep apnea during nocturnal peritoneal dialysis is associated with reduced airway congestion and better uremic clearance. Clin J Am Soc Nephrol 2009; 4: 410-418
67. Lyons OD, Chan CT, Yadollahi A, Bradley TD. Effect of ultrafiltration on sleep apnea and sleep structure in patients with end-stage renal disease. Am J Respir Crit Care Med 2015; 191: 1287-1294
68. Tang SC, Lam B, Ku PP, Leung WS, Chu CM, Ho YW, Ip MS, Lai KN. Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-Assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2006; 17: 2607-2616
69. Tang SC, Lam B, Lai AS, Pang CB, Tso WK, Khong PL, Ip MS, Lai KN. Improvement in sleep apnea during nocturnal peritoneal dialysis is associated with reduced airway congestion and better uremic clearance. Clin J Am Soc Nephrol 2009; 4: 410-418
70. Lee JJ, Kim GS, Kim JA, Kim SJ, Kang JG, Kim GH, Jung HH. Improvement of sleep-related breathing disorder in patients with end-stage renal disease after kidney transplantation. Clin Transplant 2011; 25: 126-130
71. Rodrigues CJ, Marson O, Togeiro SM, Tufik S, Ribeiro AB, Tavares A. Sleep-disordered breathing changes after kidney transplantation: a polysomnographic study. Nephrol Dial Transplant 2010; 25: 2011-2015
72. Kasai T, Bradley TD, Friedman O, Logan AG. Effect of intensified diuretic therapy on overnight rostral fluid shift and obstructive sleep apnoea in patients with uncontrolled hypertension. J Hypertens 2014; 32: 673-680
73. Gaddam K, Pimenta E, Thomas SJ, Cofield SS, Oparil S, Harding SM, Calhoun DA. Spironolactone reduces severity of obstructive sleep apnea in patients with resistant hypertension: a preliminary report. J Hum Hypertens 2010; 24: 532-537
74. Cicolin A, Mangiardi L, Mutani R, Bucca C. Angiotensin-converting enzyme inhibitors and obstructive sleep apnea. Mayo Clin Proc 2006; 81: 53-55